| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.27 | 3e-08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.04 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0007 |